In conclusion, our case supports that inhaled GM‐CSF has been safe and effective in the treatment of aPAP and represents a therapeutic option after resistance or contraindication to therapeutics whole lung lavage. This evidence concerns the gene CSF2 and autoimmune pulmonary alveolar proteinosis.